BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
94.95
-0.45 (-0.47%)
At close: Mar 28, 2025, 4:00 PM
94.00
-0.95 (-1.00%)
After-hours: Mar 28, 2025, 7:37 PM EDT
BioNTech SE Employees
BioNTech SE had 6,772 employees as of December 31, 2024. The number of employees increased by 639 or 10.42% compared to the previous year.
Employees
6,772
Change (1Y)
639
Growth (1Y)
10.42%
Revenue / Employee
$420,588
Profits / Employee
-$101,711
Market Cap
22.79B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 6,772 | 639 | 10.42% |
Dec 31, 2023 | 6,133 | 1,603 | 35.39% |
Dec 31, 2022 | 4,530 | 1,448 | 46.98% |
Dec 31, 2021 | 3,082 | 1,141 | 58.78% |
Dec 31, 2020 | 1,941 | 631 | 48.17% |
Dec 31, 2019 | 1,310 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
BNTX News
- 15 hours ago - CureVac Shares Rise on Patent Confirmation Amid BioNTech Lawsuit - Market Watch
- 8 days ago - Refractory Metastatic Melanoma Pipeline Report 2025, with Focus on BioNTech SE, Y-mAbs and Therapeutics Seagen - GlobeNewsWire
- 11 days ago - BioNTech's Pivot Into Oncology Still Makes It A Compelling Investment - Seeking Alpha
- 18 days ago - BioNTech SE (BNTX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 18 days ago - BioNTech Stock Drops as Sales Outlook Disappoints - Investopedia
- 18 days ago - Pfizer's COVID-19 Shot Partner BioNTech Reports Q4 Profit, But 2025 Guidance Falls Short On Expectations - Benzinga
- 18 days ago - BioNTech guides for worse-than-expected 2025 revenue decline - Reuters
- 18 days ago - BioNTech Announces Fourth Quarter and Full Year 2024 Financial Results and Corporate Update - GlobeNewsWire